| scholarly article | Q13442814 |
| P50 | author | Andrew T. Hudak | Q58841896 |
| P2093 | author name string | Mark Jones | |
| Wayne Hogrefe | |||
| Jan Groen | |||
| Elisabeth I Laderman | |||
| Emma Whitworth | |||
| Erickson Dumaual | |||
| Jim Carney | |||
| P2860 | cites work | Genital shedding of herpes simplex virus among men. | Q45730665 |
| Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment] | Q45742346 | ||
| Simplifying Likelihood Ratios. | Q55514377 | ||
| Rapid point-of-care testing for HIV-1 during labor and delivery--Chicago, Illinois, 2002 | Q73934025 | ||
| Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003 | Q24654682 | ||
| Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study | Q24791873 | ||
| Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. | Q33960473 | ||
| Genital herpes: review of the epidemic and potential use of type-specific serology | Q33975387 | ||
| Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition | Q34202179 | ||
| Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. | Q34266505 | ||
| Sorting out the new HSV type specific antibody tests | Q34313806 | ||
| Epidemiology of genital herpes simplex virus infection in developed countries | Q34317185 | ||
| Counseling and testing for HIV prevention: costs, effects, and cost-effectiveness of more rapid screening tests. | Q34404473 | ||
| Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003 | Q35531358 | ||
| Diagnostics for herpes simplex virus: is PCR the new gold standard? | Q36463219 | ||
| Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus | Q41120321 | ||
| Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. | Q41715890 | ||
| Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression | Q44226643 | ||
| Natural history of genital herpes simplex virus type 1 infection | Q44950861 | ||
| Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. | Q45704868 | ||
| Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection | Q45730664 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 159-163 | |
| P577 | publication date | 2007-11-14 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood | |
| P478 | volume | 15 |
| Q33948041 | A novel quantum dots-based point of care test for syphilis |
| Q52647635 | Applications of gold nanoparticles in virus detection. |
| Q57528836 | Bioinspired Functionalized Nanoparticles as Tools for Detection, Quantification and Targeting of Biomolecules |
| Q28391493 | Development and evaluation of an immunochromatographic strip for rapid detection of porcine hemagglutinating encephalomyelitis virus |
| Q45368262 | Development of an immunochromatographic strip for serological diagnosis of Porcine hemagglutinating encephalomyelitis virus |
| Q28393777 | Emerging nanotechnology-based strategies for the identification of microbial pathogenesis |
| Q50525827 | European guideline for the management of genital herpes, 2010. |
| Q91843205 | Evaluation of a nanophosphor lateral-flow assay for self-testing for herpes simplex virus type 2 seropositivity |
| Q44407012 | Evaluation of a new point-of-care serologic assay for herpes simplex virus type 2 infection. |
| Q33914355 | Gold nanoparticles: preparation, properties, and applications in bionanotechnology |
| Q99552051 | Herpes simplex virus-2 infections in pregnant women from South Africa: Evaluation of the ImmunoFLOW rapid test |
| Q36825131 | Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine |
| Q57142916 | Lateral Flow Test for Visual Detection of Multiple MicroRNAs |
| Q33857558 | Multiplexed enrichment and detection of malarial biomarkers using a stimuli-responsive iron oxide and gold nanoparticle reagent system |
| Q37636846 | Nanobioimaging and sensing of infectious diseases |
| Q33646202 | Performance of HSV-2 type specific serological tests in men in Kenya |
| Q40740482 | Rapid Detection of Escherichia coli O157 and Shiga Toxins by Lateral Flow Immunoassays |
| Q38940938 | Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections. |
| Q33447347 | Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device |
| Q34081123 | The golden age: gold nanoparticles for biomedicine |
| Q28392595 | The optical, photothermal, and facile surface chemical properties of gold and silver nanoparticles in biodiagnostics, therapy, and drug delivery |
Search more.